Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 2
Submit an article Journal homepage
474
Views
8
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Changing patterns of chemotherapy relative dose intensity and supportive care for aggressive B-cell non-Hodgkin lymphoma

Gary H. LymanHutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USACorrespondence[email protected]
,
Jeffrey CrawfordDuke University and Duke Cancer Institute, Durham, NC, USA
,
Dianne TomitaAmgen Inc., Thousand Oaks, CA, USA
,
Sadie WhittakerAmgen Inc., Thousand Oaks, CA, USA
&
David C. DaleUniversity of Washington, Seattle, WA, USA
Pages 283-290 | Received 08 Oct 2014, Accepted 24 Apr 2015, Published online: 07 Jul 2015

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michelle Shayne, R. Donald Harvey & Gary H. Lyman. (2021) Prophylaxis and treatment strategies for optimizing chemotherapy relative dose intensity. Expert Review of Anticancer Therapy 21:10, pages 1145-1159.
Read now

Articles from other publishers (7)

Nikolaus Christian Simon Mezger, Lucia Hämmerl, Mirko Griesel, Tobias Paul Seraphin, Yvonne Walburga Joko-Fru, Jana Feuchtner, Annelle Zietsman, Jean-Félix Péko, Fisihatsion Tadesse, Nathan Gyabi Buziba, Henry Wabinga, Mary Nyanchama, Eric Chokunonga, Mamadou Kéita, Guy N’da, Cesaltina Ferreira Lorenzoni, Marie-Thérèse Akele-Akpo, Jörg Michael Mezger, Mascha Binder, Biying Liu, Marcus Bauer, Oliver Henke, Ahmedin Jemal & Eva Johanna Kantelhardt. (2023) Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort. The Oncologist 28:11, pages e1017-e1030.
Crossref
Nicole M. Kuderer, Aakash Desai, Maryam B. Lustberg & Gary H. Lyman. (2022) Mitigating acute chemotherapy-associated adverse events in patients with cancer. Nature Reviews Clinical Oncology 19:11, pages 681-697.
Crossref
Douglas W. Blayney & Lee Schwartzberg. (2022) Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review. Cancer Treatment Reviews 109, pages 102427.
Crossref
Masahiro Yokoyama, Yoshiharu Kusano, Norihito Inoue, Noriko Nishimura, Yuko Mishima, Tomoyuki Nukada, Kiyohiko Hatake & Yasuhito Terui. (2021) Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis). BMC Cancer 21:1.
Crossref
Jonathan Farhi, Kamel Laribi, Corentin Orvain, Jean-François Hamel, Mélanie Mercier, Aurélien Sutra Del Galy, Aline Clavert, Marie-Christine Rousselet, Aline Tanguy-Schmidt, Mathilde Hunault-Berger & Marie-Pierre Moles-Moreau. (2018) Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma. Annals of Hematology 97:12, pages 2391-2401.
Crossref
Abiy AgiroQinli MaAnupama Kurup AchesonSze-jung WuDebra A. PattJohn J. BarronJennifer L. MalinAlan RosenbergRichard L. SchilskyGary H. Lyman. (2016) Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors With Chemotherapy for Breast Cancer. Journal of Clinical Oncology 34:32, pages 3872-3879.
Crossref
Alexandre Vainchtock, Florence Boudevin, Gwendoline Chaize, Baptiste Jouaneton & Isabelle Durand-Zaleski. (2016) Estimation de la fréquence et des coûts associés aux neutropénies fébrile en France : analyse de la base de données des hôpitaux (PMSI) 2010/2011. Journal de gestion et d'économie médicales Vol. 34:1, pages 17-32.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.